Patents by Inventor Stephen Taglienti

Stephen Taglienti has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Therapeutic Composition and Methods
    Publication number: 20240050464
    Abstract: In exemplary embodiments, the disclosure provides a Colesevelam Colon Specific Drug Delivery System for use in treatment of, for example pruritus, a disorder related to elevated serum cholesterol concentration, or reducing elevated low-density lipoprotein cholesterol (LDL) concentration in a patient.
    Type: Application
    Filed: September 25, 2023
    Publication date: February 15, 2024
    Applicant: Viscera Labs, Inc.
    Inventors: Stephen TAGLIENTI, Steven L. PETRUCCELLI
  • Therapeutic composition and methods
    Patent number: 11813283
    Abstract: In exemplary embodiments, the disclosure provides a Colesevelam Colon Specific Drug Delivery System for use in treatment of, for example insufficient glycemic control in a patient.
    Type: Grant
    Filed: November 28, 2022
    Date of Patent: November 14, 2023
    Assignee: Viscera Labs, Inc.
    Inventors: Stephen Taglienti, Steven L. Petruccelli
  • Therapeutic Composition And Methods
    Publication number: 20230091918
    Abstract: In exemplary embodiments, the disclosure provides a Colesevelam Colon Specific Drug Delivery System for use in treatment of, for example insufficient glycemic control in a patient.
    Type: Application
    Filed: November 28, 2022
    Publication date: March 23, 2023
    Inventors: Stephen TAGLIENTI, Steven L. PETRUCCELLI
  • Therapeutic composition and methods
    Patent number: 11590161
    Abstract: In exemplary embodiments, the disclosure provides a Colesevelam Colon Specific Drug Delivery System for use in treatment of, for example, cholestasis and/or cholestatic pruritus.
    Type: Grant
    Filed: February 12, 2020
    Date of Patent: February 28, 2023
    Assignee: Viscera Labs, Inc.
    Inventors: Stephen Taglienti, Steven L. Petruccelli
  • Therapeutic composition and methods
    Patent number: 11524029
    Abstract: In exemplary embodiments, the disclosure provides a Colesevelam Colon Specific Drug Delivery System for use in treatment of, for example, cholestasis and/or cholestatic pruritus.
    Type: Grant
    Filed: August 12, 2019
    Date of Patent: December 13, 2022
    Assignee: Viscera Labs, Inc.
    Inventors: Stephen Taglienti, Steven L. Petruccelli
  • THERAPEUTIC COMPOSITION AND METHODS
    Publication number: 20200179292
    Abstract: In exemplary embodiments, the disclosure provides a Colesevelam Colon Specific Drug Delivery System for use in treatment of, for example, cholestasis and/or cholestatic pruritus.
    Type: Application
    Filed: February 12, 2020
    Publication date: June 11, 2020
    Inventors: Stephen Taglienti, Steven L. Petruccelli